BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

825 related articles for article (PubMed ID: 29478221)

  • 1. Mild cognitive impairment in Parkinson's disease: the Parkinson's disease cognitive study (PACOS).
    Monastero R; Cicero CE; Baschi R; Davì M; Luca A; Restivo V; Zangara C; Fierro B; Zappia M; Nicoletti A
    J Neurol; 2018 May; 265(5):1050-1058. PubMed ID: 29478221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mild Behavioral Impairment in Parkinson's Disease: Data from the Parkinson's Disease Cognitive Impairment Study (PACOS).
    Baschi R; Restivo V; Nicoletti A; Cicero CE; Luca A; Recca D; Zappia M; Monastero R
    J Alzheimers Dis; 2019; 68(4):1603-1610. PubMed ID: 30909234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia.
    Galtier I; Nieto A; Lorenzo JN; Barroso J
    J Clin Exp Neuropsychol; 2016; 38(1):40-50. PubMed ID: 26602176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subtypes of mild cognitive impairment in patients with Parkinson's disease: evidence from the LANDSCAPE study.
    Kalbe E; Rehberg SP; Heber I; Kronenbuerger M; Schulz JB; Storch A; Linse K; Schneider C; Gräber S; Liepelt-Scarfone I; Berg D; Dams J; Balzer-Geldsetzer M; Hilker R; Oberschmidt C; Witt K; Schmidt N; Mollenhauer B; Trenkwalder C; Spottke A; Roeske S; Wittchen HU; Riedel O; Dodel R
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1099-105. PubMed ID: 27401782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and Correlates of Subjective Memory Complaints in Parkinson's Disease with and without Mild Cognitive Impairment: Data from the Parkinson's Disease Cognitive Impairment Study.
    Baschi R; Nicoletti A; Restivo V; Recca D; Zappia M; Monastero R
    J Alzheimers Dis; 2018; 63(3):1015-1024. PubMed ID: 29710711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson's disease.
    Poletti M; Frosini D; Pagni C; Baldacci F; Nicoletti V; Tognoni G; Lucetti C; Del Dotto P; Ceravolo R; Bonuccelli U
    J Neurol Neurosurg Psychiatry; 2012 Jun; 83(6):601-6. PubMed ID: 22492216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical differences among mild cognitive impairment subtypes in Parkinson's disease.
    Goldman JG; Weis H; Stebbins G; Bernard B; Goetz CG
    Mov Disord; 2012 Aug; 27(9):1129-36. PubMed ID: 22778009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease.
    Goldman JG; Holden S; Bernard B; Ouyang B; Goetz CG; Stebbins GT
    Mov Disord; 2013 Dec; 28(14):1972-9. PubMed ID: 24123267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective assessment of movement disorder society criteria for mild cognitive impairment in Parkinson's disease.
    Loftus AM; Bucks RS; Thomas M; Kane R; Timms C; Barker RA; Gasson N
    J Int Neuropsychol Soc; 2015 Feb; 21(2):137-45. PubMed ID: 25666735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mild Cognitive Impairment in Early Parkinson's Disease Using the Movement Disorder Society Task Force Criteria: Cross-Sectional Study in Hoehn and Yahr Stage 1.
    Stefanova E; Žiropadja L; Stojković T; Stanković I; Tomić A; Ječmenica-Lukić M; Petrović I; Kostić V
    Dement Geriatr Cogn Disord; 2015; 40(3-4):199-209. PubMed ID: 26226988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An assessment of Movement Disorder Society Task Force diagnostic criteria for mild cognitive impairment in Parkinson's disease.
    Uysal-Cantürk P; Hanağası HA; Bilgiç B; Gürvit H; Emre M
    Eur J Neurol; 2018 Jan; 25(1):148-153. PubMed ID: 28941002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular risk factors, white matter lesions and cognitive impairment in Parkinson's disease: the PACOS longitudinal study.
    Nicoletti A; Luca A; Baschi R; Cicero CE; Mostile G; Davì M; La Bianca G; Restivo V; Zappia M; Monastero R
    J Neurol; 2021 Feb; 268(2):549-558. PubMed ID: 32865628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosing mild cognitive impairment in Parkinson's disease: which tests perform best in the Italian population?
    Federico A; Trentin M; Zanette G; Mapelli D; Picelli A; Smania N; Tinazzi M; Tamburin S
    Neurol Sci; 2017 Aug; 38(8):1461-1468. PubMed ID: 28550344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroanatomical changes in early Parkinson's disease with mild cognitive impairment: a VBM study; the Parkinson's Disease Cognitive Impairment Study (PaCoS).
    Donzuso G; Monastero R; Cicero CE; Luca A; Mostile G; Giuliano L; Baschi R; Caccamo M; Gagliardo C; Palmucci S; Zappia M; Nicoletti A
    Neurol Sci; 2021 Sep; 42(9):3723-3731. PubMed ID: 33447925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphometric magnetic resonance imaging cortico-subcortical features in Parkinson's disease with mild cognitive impairment.
    Cicero CE; Donzuso G; Luca A; Davì M; Baschi R; Mostile G; Giuliano L; Palmucci S; Salerno A; Monastero R; Nicoletti A; Zappia M
    Eur J Neurol; 2022 Nov; 29(11):3197-3204. PubMed ID: 35790057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the utility of the Movement Disorder Society Task Force Level 1 diagnostic criteria for mild cognitive impairment in Parkinson's disease.
    Szeto JY; Mowszowski L; Gilat M; Walton CC; Naismith SL; Lewis SJ
    Parkinsonism Relat Disord; 2015 Jan; 21(1):31-5. PubMed ID: 25465744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical characteristics and cognitive features of mild cognitive impairment in Parkinson's disease and the analysis of relevant factors.
    Nie K; Gao Y; Mei M; Guo M; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    J Clin Neurosci; 2019 May; 63():142-148. PubMed ID: 30732989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular autonomic function and MCI in Parkinson's disease.
    Cicero CE; Raciti L; Monastero R; Mostile G; Donzuso G; Sciacca G; Luca A; Terravecchia C; Giuliano L; Baschi R; Davì M; Zappia M; Nicoletti A
    Parkinsonism Relat Disord; 2019 Dec; 69():55-58. PubMed ID: 31677456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A neurophysiological profile in Parkinson's disease with mild cognitive impairment and dementia in China.
    Wang YQ; Tang BS; Yan XX; Chen ZH; Xu Q; Liu ZH; Li K; Wang K; Guo JF
    J Clin Neurosci; 2015 Jun; 22(6):981-5. PubMed ID: 25890772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.